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Open access under the ElsA large majority of the 1000–1500 proteins in the mitochondria are encoded by the nuclear genome, and
therefore, they are translated in the cytosol in the form and contain signals to enable the import of pro-
teins into the organelle. The TOM complex is the major translocase of the outer membrane responsible for
preprotein translocation. It consists of a general import pore complex and two membrane import recep-
tors, Tom20 and Tom70. Tom70 contains a characteristic TPR domain, which is a docking site for the
Hsp70 and Hsp90 chaperones. These chaperones are involved in protecting cytosolic preproteins from
aggregation and then in delivering them to the TOM complex. Although highly signiﬁcant, many aspects
of the interaction between Tom70 and Hsp90 are still uncertain. Thus, we used biophysical tools to study
the interaction between the C-terminal domain of Hsp90 (C-Hsp90), which contains the EEVD motif that
binds to TPR domains, and the cytosolic fragment of Tom70. The results indicate a stoichiometry of bind-
ing of one monomer of Tom70 per dimer of C-Hsp90 with a KD of 360 ± 30 nM, and the stoichiometry and
thermodynamic parameters obtained suggested that Tom70 presents a different mechanism of interac-
tion with Hsp90 when compared with other TPR proteins investigated.
 2011 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Mitochondria, which are ubiquitous in eukaryotic cells types,
are crucial to many physiological functions [1,2], and they have
critical roles in physiological and pathological processes and act
as cellular ‘‘powerhouses’’. In addition to being vital for energy pro-
duction and therefore for the survival of eukaryotic cells, mito-
chondria are implicated in a number of other essential functions,
such as cellular respiration, metabolism of lipids, amino acids, iron
homeostasis, and the regulation of intrinsic pathway of apoptosis
[3–5].
Mitochondria are double-membrane bound organelles that
include four compartments: the outer membrane, the inner mem-
brane, the intermembrane space and the mitochondrial matrix. In
the interior of the mitochondria, about 1000–1500 different pro-
teins are present, of which only a small fraction are encoded by
the mitochondrial genomic DNA [4,6]. The vast majority of mito-
chondrial proteins are encoded by the nuclear genome, translated
by cytosolic ribosomes in the form of preproteins and thereafterry, University of Campinas
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evier OA license.translocated into the mitochondria [6–8]. Preproteins targeted spe-
ciﬁcally to the mitochondria contain signals to localize to the cor-
rect compartments within the organelle. The signals are recognized
by cytosol-exposed receptors located in the mitochondrial outer
membrane [4]. Following recognition, these signals are decoded
by mitochondrial translocases, which contain multifunctional
components that coordinate the preprotein transfer to the translo-
cation pore and that control the sorting and communication with
subsequent translocases [1,6,8]. Thus, the machineries of import-
ing and sorting proteins into the mitochondria are greatly impor-
tant in maintaining proper mitochondrial function.
A major translocase of the outer membrane is the TOM com-
plex. It consists of the general import pore (GIP) complex and
two membrane import receptors, Tom20 and Tom70, with a single
N-terminal transmembrane domain and a receptor domain
exposed into the cytosol [5,8]. Tom20 recognizes the N-terminal
mitochondrial targeting signals from the preproteins, via hydro-
phobic interactions, while Tom70 preferentially recognizes prepro-
teins with internal hydrophobic targeting sequences, such as the
inner membrane metabolite carriers [4,5,9–12]. The Tom70-medi-
ated import pathway is chaperone dependent. Molecular chaper-
ones Hsp70 and Hsp90 have important roles in targeting the
preproteins to the TOM complex and in the protection of these
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cytosolic TPR (tetratricopeptide repeat) clamp domain that serves
as a docking site for the Hsp70 and Hsp90 C-terminal EEVD motifs
and consequently for the multi-chaperone complexes that hold the
preprotein. The C-terminal EEVD motif of the chaperones has been
implicated in the binding of other proteins containing TPR regions,
including Hop and CHIP co-chaperones [14–18]. The ATPase cycles
of Hsp70/Hsp90 control interactions with substrates and client
proteins and are also needed for the chaperones to assist in protein
folding; in addition, preproteins are transferred in an ATP-
dependent way to the TOM complex for translocation [19]. Speciﬁc
Hsp90 inhibitors reduce the Tom-dependent import to a basal
level, indicating that the chaperone has a signiﬁcant role in protein
import into the mitochondria via the TOM complex [19]; however,
many aspects of the Tom70–Hsp90 interaction are still not clear.
For instance, the details of the mechanism of interaction and the
structure of the complex remain unclear. In a previous work, we
showed that the functional state of human Tom70 is monomeric
[5], and here, we present the stoichiometry and thermodynamic
parameters of its interaction with the C-terminal domain of
Hsp90, which is a dimer in solution.
Materials and methods
Plasmids, recombinant protein expression and puriﬁcation
The coding sequences for the C-terminus fragment of human
Hsp90a, C-Hsp90, (NCBI Accession No.: AAI21063, residues
566–732) and the cytosolic fragment of human Tom70 (NCBI
Accession No.: O94826.1, residues 111–608) cloned into a
pProExHta (Invitrogen), which inserts a His-tag followed by a
cleavage site for the TEV-protease, were a generous gift from Dr.
Jason C. Young [14]. Both recombinant proteins were expressed
in BL21(DE3) Escherichia coli cells and were induced with 0.8 mM
isopropyl b-D-thiogalactoside at 37 C for 4 h. His-tagged proteins
were puriﬁed using a nickel–Sepharose 5 mL column (GE Health-
care) equilibrated in 20 mM sodium phosphate, pH 7.4, 500 mM
NaCl and 20 mM imidazole, and they were eluted with 20 mM so-
dium phosphate, pH 7.4, 500 mM NaCl and 150 mM imidazole.
Proteins were further puriﬁed over a Superdex 200 26/60 gel ﬁltra-
tion column (GE Healthcare) in 20 mM Tris–HCl, pH 8.0, 150 mM
NaCl using an ÄKTA FPLC instrument (GE). Protein puriﬁcation
was assessed by SDS–PAGE, and concentrations were determined
using the absorbance at 280 nm.
Spectroscopic and hydrodynamic experiments of C-Hsp90
Circular dichroism (CD)1 measurements were recorded on a
Jasco J-810 spectropolarimeter (JASCO, Inc.) with temperature con-
trolled by a Peltier-type system (PFD 425S). Data were collected at
20 C using a 1 mm pathlength cuvette, in 20 mM Tris–HCl, pH 8.0,
and 150 mM NaCl with a protein concentration of 10 lM. Fluores-
cence measurements were done in a SLM AMINCO-Bowman Series
2 (AB2) spectroﬂuorimeter (Thermo Fisher Scientiﬁc, Inc.) using a
1  1 cm pathlength cuvette with 10 lM of C-Hsp90, in the same
buffer as for the CD experiments. Excitation was at 295 nm and
emission was measured from 300 to 420 nm (emission and excita-
tion bandpass of 4 nm). Fluorescence data were evaluated by their
emission maxima wavelength (kmax) and by their spectral center of
mass ðhkiÞ, as described by the equation:1 Abbreviations used: C-Hsp90, Hsp90 C-terminal domain; CD, circular dichroism;
ITC, isothermal titration calorimetry; KD, dissociation constant; SEC-MALS, size-
exclusion chromatography coupled to multi-angle light scattering; SE, sedimentation
equilibrium; MM, molecular mass; Tom70, translocase of the outer membrane.hki ¼
P
kiFiP
Fi
ð1Þ
where ki is each wavelength and Fi is the ﬂuorescence intensity at
k1.
Analytical ultracentrifugation experiments were conducted
with a Beckman Optima XL-A analytical ultracentrifuge and an
AN-60Ti rotor (for review, see [20]). Sedimentation equilibrium
(SE) experiments were performed at protein concentrations from
200 to 600 lg/mL (approximately 5–15 lM of dimeric C-Hsp90),
in a buffer containing 20 mM Tris–HCl, pH 8.0, and 150 mM NaCl
at 20 C, from 9000 to 13,000 rpm, and data acquisition was at
276 nm. The software SEDPHAT version 8.2 was applied to evalu-
ate the SE data [21]. The partial speciﬁc volume of the protein, buf-
fer density and viscosity were calculated with the program
SEDNTERP [22]. The global ﬁtting was accomplished with the ‘‘Spe-
cies Analysis’’ model of the SEDPHAT program. All parameters were
allowed to ﬂoat freely, and then, the statistical analyses were per-
formed. The statistical method used was the ‘‘Monte-Carlo non-lin-
ear regression’’ with at least 100 iterations and a conﬁdence level
of 0.68. Tom70 was similarly analyzed by CD, and ﬂuorescence
spectroscopy and analytical ultracentrifugation were performed
as described in a previous work by some of the authors [5].
Pull-down experiments
The experiments were conducted at room temperature. The
His-tag of C-Hsp90 was removed by the TEV-protease so that C-
Hsp90 could be used as the prey in the pull-down assays, while
the His-tag of Tom70 was maintained to be used as the bait.
Pull-down experiments were performed in equilibrium buffer
(50 mM sodium phosphate, 300 mM NaCl, pH 8.0), with 50 lM of
His6–Tom70 and 25 lM (dimer concentration) of cleaved C-
Hsp90. Proteins were mixed and incubated for 2 h, and then,
100 lL of nickel–agarose resin Ni–NTA (Qiagen) was added, and
the mixture was further incubated for 2 h. The resin was washed
four times with 200 lL aliquots of equilibrium buffer added to
20 mM imidazole to release proteins bound nonspeciﬁcally to the
resin. Proteins bound speciﬁcally to the resin and any proteins
interacting with them were eluted with the equilibrium buffer
added to 200 mM imidazole, precipitated with acetone, solubilized
in sample buffer and analyzed by Coomassie-stained SDS–PAGE.
Size-exclusion chromatography–multiple angle light scattering (SEC–
MALS)
The oligomeric states of Tom70, C-Hsp90 and their complex
were estimated via SEC–MALS measurements on an ÄKTA FPLC
system (GE Healthcare) connected to a triple-angle static light-
scattering detector miniDAWN™ TREOS (Wyatt Technology, Santa
Barbara, CA, USA). A Superdex 200 HR 10/300 GL column (GE
Healthcare) was used in 20 mM Tris–HCl, pH 8.0, and 150 mMNaCl
at a ﬂow rate of 0.5 mL/min. Sample volumes of 250 lL were
injected at a concentration of approximately 100 lM of Tom70
and 50 lM of C-Hsp90 (dimer concentration). The data were re-
corded and processed using ASTRA V software (Wyatt Technology,
Santa Barbara, CA, USA). To determine the detector delay volumes
and normalization coefﬁcients for the light scattering detector, a
BSA sample (Sigma–Aldrich) was used as a reference. SEC–MALS
is an absolute method for molecular mass determination; it pro-
vides a direct measure of molecular mass without being limited
by the molecular shape or hydrodynamic parameters. The signal
from the light-scattering detector is directly proportional to the
molecular mass of the protein multiplied by their concentrations
(mg/mL). This signal and the concentration (determined by absor-
bance, for example) make it possible to measure the molecular
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technique to determine the molecular mass and stoichiometry of
protein–protein complexes. All elution peaks were collected in
0.5 mL aliquots and were assessed by Coomassie-stained SDS–
PAGE.Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) experiments were per-
formed at 20 C using a VP-ITC calorimeter (Microcal, LLC, North-
ampton, MA, USA) running Origin version 5.0 software. All
solutions were thoroughly degassed before use by stirring under
vacuum, and protein samples were dialyzed against 20 mM Tris–
HCl, pH 8.0, and 150 mM NaCl. Tris buffer was used to facilitate
the comparison with previous works ([25] and references therein)
and to eliminate possible artifactual results caused by the interac-
tion of phosphate with a putative additional nucleotide binding
site in the C-terminus of Hsp90 [25] (see also Results and discus-
sion). Titrations consisted of 5 lL injections of 109 lM Tom70
every 300 s into 5 lM C-Hsp90 solutions (dimer concentration).
The enthalpy change for each injection was calculated by integrat-
ing the area under the peaks of the recorded time course of the
change of power and then by subtracting that of the control titra-
tion. The control experiments were used to correct for heat effects
of dilution and mixing, and they consisted of injections of buffer
without protein into buffer. The heat of dilution was determined
from the baseline at the end of titration and was negligible. The
apparent enthalpy change of binding (DHapp, i.e. the sum of all
events involved in the interaction), binding stoichiometry (n),
and dissociation constant (KD) were estimated from the best ﬁt
of the theoretical titration curve using a least squares ﬁtting anal-
ysis (Origin 5.0).Fig. 1. (A) Circular dichroism spectrum of recombinant human C-Hsp90. Mean
residue ellipticity ([h]) was measured from 198 to 260 nm at a protein concentra-
tion of 10 lM, in 20 mM Tris–HCl, pH 8.0, with 150 mM NaCl at 20 C, using a Jasco
J-810 spectropolarimeter. The spectrum indicates that C-Hsp90 is folded and, by
applying simple methods proposed by Morriset et al. [33] and Greenﬁeld and
Fasman [34], has about 26% and 37% a-helix and b-sheet content, respectively. (B)
Emitted ﬂuorescence spectrum of recombinant human C-Hsp90. Emission trypto-
phan ﬂuorescence was measured from 300 to 420 nm; the excitation was at 295 nm
at a protein concentration of 10 lM, using a SLM AMINCO-Bowman Series 2 (AB2)
spectroﬂuorimeter. C-Hsp90 has one Trp residue, and the emission ﬂuorescence
spectrum had a maximum intensity at 343 ± 1 nm with a spectral center of mass at
341 ± 1 nm suggesting that the residue was well-buried in the protein structure.Results and discussion
The C-terminus of Hsp90 was produced folded as a dimer in solution
The 90 kDa heat shock protein Hsp90 is one of the most impor-
tant molecular chaperones, and it has only one homolog in pro-
karyotes, whereas in humans there are at least four homologs,
two cytosolic, one in the mitochondria and one in the endoplasmic
reticulum. Hsp90 is essential for survival in eukaryotes, and its cli-
ent proteins are normally associated with cell cycling and signal-
ing, and this association makes this chaperone a potential drug
target [26–28]. Hsp90 is an elongated dimer in solution with the
dimerization site located in the C-terminal domain [29–31], and
it can be divided into speciﬁc domains, the N-terminal domain fol-
lowed by a linker, the M or middle domain, and the C-terminal do-
main, which has the EEVD motif that is involved in the binding to
proteins presenting the TPR domain. In the case of the inducible
cytosolic Hsp90a, the N-terminal domain comprises residues 1–
210, the linker comprises residues 211–272, the M or middle do-
main comprises residues 273–629, and the C-terminal domain
comprises residues 630–732 [26]. The EEVD motif is located at res-
idues 729–732 and is essential for Hsp90 binding to its co-chaper-
one by the TPR domain present in these proteins. To gain insight
into the mechanism by which Hsp90 interacts with Tom70, we
puriﬁed a recombinant C-terminus fragment of human Hsp90a
(C-Hsp90) using a modiﬁed approach and characterized its folded
state.
C-Hsp90 was pure and soluble (data not shown). Its CD spec-
trum is characteristic of a folded protein [32] with minima at
209 nm (10,840 deg cm2 dmol1) and 222 nm (10,670
deg cm2 dmol1) as shown in Fig. 1A. By applying the simple pre-
diction methods proposed by Morriset et al. [33] and Greenﬁeldand Fasman [34], the percentage of a-helix and b-sheet were esti-
mated to be of approximately 26% and 37%, respectively. These
percentages are in good agreement with the crystal structure of
the C-terminus of the Hsp90 homolog from Saccharomyces cerevisi-
ae (PDB ID: 2CG9), in which the C-terminus comprises a three-
stranded b-sheet positioned under a curved helix that faces a
three-helix coil [35]. Emission ﬂuorescence spectroscopy of trypto-
phan (Trp) is a reasonable method to access information regarding
the environment where this residue is situated in a protein,
because of its sensitivity to the polarity of this environment; thus,
Trp is a local probe of the folded state of a protein [36]. C-Hsp90
has one Trp residue. The emission ﬂuorescence spectrum had its
maximum intensity at 343 ± 1 nm with a spectral center of mass
at 341 ± 1 nm (Fig. 1B), suggesting that the residue was well-bur-
ied in the protein structure. This result is another indication that
the protein was pure.
Sedimentation equilibrium analytical ultracentrifugation was
used to determine the molecular mass (MM) and thus the oligo-
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centrations at ﬁve different speeds were analyzed globally with
SEDPHAT (see Materials and methods). Fig. 2 shows the results
using 600 lg/mL protein with the residuals from ﬁtting shown in
the upper panel. As determined by the ﬁtting and the Monte-Carlo
statistics analysis, C-Hsp90 has a molecular mass of 43 ± 1 kDa,
which is consistent with a dimer in solution, since the MM pre-
dicted from the primary structure for the recombinant monomer
is 21850.75 Da. Taken together, our results indicate that C-Hsp90
is properly folded and is a dimer.Fig. 3. Pull-down assays of Tom70 and C-Hsp90. The Tom70 His-tagged construct
was maintained intact whereas C-Hps90 had its His-tag cleaved by TEV-protease to
be used as bait in pull-down assays. SDS–PAGE analysis of samples bound to the Ni–
NTA resin that eluted in the presence of 200 mM imidazole (see Materials and
methods). Lane 1, molecular mass marker (BenchMark™ Protein Ladder from
Invitrogen); lane 2, Tom70 used as control; lane 3, Tom70 C-Hsp90 mixture; and
lane 4, C-Hsp90 used as control. His-tagged Tom70 was capable of binding to C-
Hsp90 and pulled it out of solution, conﬁrming their interaction (lane 3).Stoichiometry and thermodynamics of the interaction between C-
Hsp90 and Tom70
The characterization of the folded conformation and oligomeric
state of the recombinant cytosolic fragment of human Tom70 has
been described previously [5], where we and our collaborators
showed that the protein is puriﬁed in its natively folded state,
has high a-helix content and is a functional monomer. Since both
C-Hsp90 and Tom70 are well-behaved single species in solution,
we undertook the measurement of their interaction. The interac-
tion was initially studied by pull-down assays. For that examina-
tion, the Tom70 His-tagged construct was maintained intact to
be used as bait in pull-down assays, since it was capable of binding
to a nickel resin, whereas C-Hsp90 had it His-tag cleaved by TEV-
protease. The results were assessed by PAGE in denaturing condi-
tions by SDS (Fig. 3). The experiment showed that His-tagged
Tom70 bound the resin as expected and free C-Hsp90, which has
the His-tag removed did not (Fig. 3). However, when mixed with
Tom70, C-Hsp90 remained bound to the resin even after twoFig. 2. Analytical ultracentrifugation sedimentation equilibrium of C-Hsp90. SE
experiments were made at protein concentrations from 200 to 600 lg/mL
(approximately 5–15 lM of dimeric C-Hsp90), in 20 mM Tris–HCl, pH 8.0, and
150 mM NaCl at 20 C, from 9000 to 13,000 rpm, and data were acquired at 276 nm.
The data analysis was performed with the software SEDPHAT version 8.2, and
hydrodynamic parameters were calculated with SEDNTERP. Global reduced v2 was
approximately 1.07, and the local rmsd was approximately 0.0052. The ﬁtting and
Monte-Carlo statistics indicated that C-Hsp90 is a dimer in solution, with a
molecular mass of 43 ± 1 kDa, consistent with the known data for full-length Hsp90.washes and was released only when imidazole was used to
decrease the afﬁnity of His-tagged Tom70 for the resin (Fig. 3).
Therefore, these results demonstrate that C-Hsp90 in fact inter-
acted with Tom70. We then set out to determine the oligomeric
state of the proteins in the complex by measuring the MM of the
complex. We used size-exclusion chromatography combined with
multi-angle static light scattering (SEC–MALS), a technique that
provides a precise determination of MM independent of molecular
shape or hydrodynamic parameters, to determine the MM of the
complex (Fig. 4). Fig. 4A shows the SEC–MALS measurements of
isolated proteins as normalized light scattering proﬁles and respec-
tive molecular mass distributions. Fig. 4B and C show the SDS–
PAGE proﬁles of free Tom70 and free C-Hsp90 (B) and their
mixture (C) from SEC–MALS, to conﬁrm the presence of the pro-
teins. As expected, free C-Hsp90 had a MM of 43 kDa (Fig. 4A
and B), which is in excellent agreement with the theoretically cal-
culated MM of 43.7 kDa for a dimer, corroborating SE results (see
above), and free Tom70 had a MM of 62 kDa (Fig. 4A and B), con-
sistent with the theoretical calculated MM of 59.7 kDa for a mono-
mer, which is supported by previously analysis of its oligomeric
state in solution [5]. Mixed Tom70 and C-Hsp90 eluted as a single
peak with a MM of 110 kDa (Fig. 4A and C), indicating a stoichi-
ometry of one monomer of Tom70 to a dimer of C-Hsp90 in the
complex.
The stoichiometry determined above by SEC–MALS was con-
ﬁrmed by isothermal titration calorimetry (ITC). In this experi-
ment, the DHapp for the binding interaction is measured at a
constant temperature, allowing for the determination of the bind-
ing stoichiometry (n) and the dissociation constant (KD) by ﬁtting
of the titration curve. Both the sequence of injections and the dif-
ferential heat plot are shown in Fig. 5. In accordance with the con-
clusion from the SEC–MALS results, the binding stoichiometry (n)
was equal to 1.2 ± 0.1, indicating that one monomer of Tom70
binds to a dimer of C-Hsp90. The KD was determined to be
360 ± 30 nM, suggesting that the complex has high afﬁnity. The
DHapp of interaction was 2.6 ± 0.1 kcal/mol, and the apparent
entropy of interaction was 21 ± 1 cal/mol K, indicating that the
interaction is driven by both enthalpy and entropy. Interestingly,
Hop and Cyp40, other TPR co-chaperones from human, bind the
Fig. 4. SEC–MALS combined with SDS–PAGE for the determination of the molecular mass of the Tom70 C-Hsp90 complex. (A) SEC–MALS measurements of the isolated
proteins and the complex are labeled. The graphic shows the representative normalized light scattering proﬁles recorded by detectors (continuous lines) and the molecular
mass distributions (open squares) per elution volume unit (mL). Free C-Hps90 had a MM of 43 kDa (consistent with a dimer), free Tom70 had a MM of 62 kDa (consistent
with a monomer) and mixed Tom70 C-Hsp90 had a MM of 110 kDa, indicating a stoichiometry of one monomer of Tom70 to a dimer of C-Hsp90 in the complex. (B and C)
Fractions of 0.5 mL from free Tom70 and free C-Hsp90 (B) and complex (C) were collected and assessed by SDS–PAGE to conﬁrm the presence of the proteins in the SEC–MALS
measurements.
Fig. 5. Binding of Tom70 to C-Hsp90 monitored by ITC. Top, the experimental
outline of the injections of Tom70 into the C-Hsp90 dimer showing thermal power,
which is proportional to the heat of each injection, as a function of time. Bottom, the
integrated heat plot. Heats of binding are represented by open squares, and the line
represents the best ﬁt of the data using the Origin 5.0 (Microcal). The binding
stoichiometry (n) was equal to 1.2 ± 0.1, indicating that one monomer of Tom70
binds to a dimer of C-Hsp90. Data analysis provided a KD value of 360 ± 30 nM,
suggesting that the complex has a high afﬁnity. The binding DH measured from a
single ITC experiment might include heat that is due to buffer ionization; therefore,
the DH measured here is referred to as DHapp and was 2.6 ± 0.1 kcal/mol. The
apparent entropy of interaction was 21 ± 1 cal/mol K indicating that the interaction
is driven by both enthalpy and entropy.
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than that of Tom70, in an interaction that is also enthalpy driven,
although the interaction with Cyp40 is driven by entropy [17,24].
It may be possible that there are slightly differences in the binding
of different TPR co-chaperones with Hsp90. There are crystal struc-
tures of the Hsp90 MEEVD motif in complex with the TPR domains
of human Hop [17] and yeast Tom 71 [4] (Fig. 6). Since the residues
of Tom71 that interact with the MEEVD motif are conserved in
human Tom70, the structure of the yeast ortholog can be used as
a model for the interaction of Tom70 with Hsp90 [4]. First, one
can observe general similarities. The interaction of the MEEVD
with the TPR domains of both Hop and Tom71 involves mainly
the dicarboxylate from the carboxy-terminal Asp residue from
MEEVD and two basic lysines from the TPR domain (Fig. 6). At
pH 8, the two lysines are positively charged while the MEEVD mo-
tif is negatively charged showing that the interaction between TPR
co-chaperones and Hsp90 is electrostatic in nature. Second, slightly
differences in binding can be observed when comparing Fig. 6A
with B and C with D. The MEEVD motif appears to be more
involved by the TPR domain when bound to Hop than when bound
to Tom71, suggesting that the interaction between the MEEVD and
Hop is more organized and thus has a higher entropic cost. In addi-
tion to that, the conformation of the MEEVD pentapeptide changes
depending on the TPR co-chaperone to which it is bound (Fig. 6).
Six residues from the Tom71 TPR domain are involved in seven
electrostatic interactions with the MEEVD motif while seven resi-
dues from the Hop TPR domain are involved in ten electrostatic
interactions with the MEEVD motif (Fig. 6A and B). The seventh
residue is an Asn in position 308 of the TPR2a from Hop that has
no equivalent in Tom71 and is hydrogen bonded to the ﬁrst Glu
residue of the MEEVD motif. A Tyr at position 236 of the TPR2a
from Hop is hydrogen bonded to the carbonyl group of the peptide
bond between the two Glu residues of the MEEVD motif (Fig. 6B),
while the correspondent residue in Tom71, Phe138, does not make
this kind of interaction (Fig. 6A). In contrast with the tight interac-
tions when bound to Hop, the N-terminus of the MEEVD motif ap-
pears to be less restrained when bound to Tom71 (Fig. 6),
indicating that although the interactions of this portion of the
motif with Hop increase enthalpy they also have an entropic cost
due to the organization of the complex. This observation is
Fig. 6. The MEEVDmotif from Hsp90 complexed with TPR domains. The structures of the MEEVD in complex with the TPR domains of yeast Tom71 (A and C) – PDB 3FP2; and
human Hop (B and D) – PDB 1ELR) are shown. Electrostatic interactions and hydrogen bounds are highlighted in panels (A) and (B) while panels (C) and (D) present the front
view of the complexes, highlighting the relative position of the dicarboxylate clamp (see text). Generated using Pymol (www.pymol.org).
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Hsp90 with Hop [24] and were performed in similar conditions to
those reported in this work. Onuoha et al. [24] showed that the
interaction between C-Hsp90 and Hop has a higher enthalpic con-
tribution than that measured for Tom70 (this work) and a negative
entropy value which is different from the interaction of C-Hsp90
with Tom70 that was entropy driven (this work). Additionally,
when bound to the TPR domain of Tom71, the Met residue of the
MEEVD motif makes hydrophobic interactions with a cleft formed
by the protein residues Leu199 and Lys196 (Fig. 6A), indicating
that the binding may have a lower apparent enthalpy of binding
but also a positive entropic contribution. This observation is also
in good agreement with our measurements on human Tom70
and is expected since hydrophobic interactions provide a higher
degree of freedom.
Finally, the stoichiometry of binding for either Hop or Cyp40 is
of one monomer per monomer of C-Hsp90-b [17,24], although
some controversy exists regarding the oligomeric state of native
Hop [37,38]. Therefore, the mode of interaction between Tom70
and C-Hsp90 appears to have speciﬁc characteristics that differ
from those of other proteins containing TPR domains. Combined,
these results suggest that the interaction of TPR proteins with Hsps
may be more complex and diverse than previously expected. More-
over, it may be possible that the interaction with only one mono-
mer of the C-Hsp90 motif allows the other to be available for
additional interactions with other TPR co-chaperones, opening up
the possibility for further functional modulation. However, more
experimental evidence is necessary to support these hypotheses.
Nevertheless, it is noteworthy that Tom70 also binds Hsp70, which
is a monomer in solution [39,40].These ﬁndings are potentially relevant because TPR–Hsp com-
plexes have been a target of several investigations because of their
potential as drug targets. Since Hsp90 is involved with the stabil-
ization of the tumor phenotype, the interference with the interac-
tion between the EEVD motif and TPR may inhibit the delivery of
client proteins to Hsp90 [27]. Many hybrid peptides that mimic
TPR domains are under investigation to substitute the general
broad effect of small molecule inhibitors by a more speciﬁc inhibi-
tion strategy that will interfere with the interaction of Hsp90 with
regulatory co-chaperones. We believe that the results presented
here are an important step toward the design of such therapeutic
strategies, and thus, they are of potential interest not only for those
studying domain–domain interactions but also for those in the
ﬁeld of translational medicine.Conclusion
Experiments using circular dichroism and intrinsic ﬂuorescence
spectroscopy were consistent with the puriﬁcation of folded re-
combinant human proteins. Analytical sedimentation equilibrium
showed that C-Hsp90 is a dimer in solution, a result corroborated
by SEC–MALS experiments. As previously reported [5], Tom70 is a
monomer in solution and interacts with C-Hsp90 forming a com-
plex in which one monomer of Tom70 binds a dimer of C-Hsp90.
The stoichiometry was conﬁrmed by isothermal titration calorim-
etry, which also yielded the thermodynamic parameters of the
interaction showing that human Tom70 has a high afﬁnity for C-
Hsp90 in comparison to other TPR proteins. The mode of binding
between Tom70 and C-Hsp90 provides new information when
L.M. Gava et al. / Archives of Biochemistry and Biophysics 513 (2011) 119–125 125compared with what is currently known for the binding of other
proteins that contain TPR domains. This information is potentially
relevant for studies aiming to interfere with the interaction be-
tween the EEVD motif and TPR as this strategy may inhibit the
delivery of client proteins to Hsp90.
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